genprowebdirectory
slug ) ){
$cat_slugs = array();
foreach( $cats as $_cat ){
// BEGIN stop if this page has anything to do with the "sponsored" category
if( "sponsored" === $_cat->slug ) {
return array( 'empty' );
}
// END of "sponsored" check
$cat_slugs[] = $_cat->slug;
}
return $cat_slugs;
}
return array( 'empty' );
}; ?>
![Cardiomyocytes (shown in green) proliferating in a mouse heart after gel injection. [University of Pennsylvania]](https://www.genengnews.com/wp-content/uploads/2018/08/Nov30_2017_UnivPenn_cardiomyocytes8911058981-265x198.jpg "microRNA Gel Helps Damaged Hearts Get to a Better Beat")
![RIBOTAC conjugates could offer new approach to destroying toxic gene products and treating genetic diseases. [The Scripps Research Institute]](https://www.genengnews.com/wp-content/uploads/2018/08/May30_2018_TheScrippsResearchInst_MatthewDisneyInLab1948183243-265x198.jpg "Small-Molecule RNA-Targeting Technology Kills Cancer Cells")
![Collaboration gives Servier ex-U.S./Japan global rights to three of Miragen’s preclinical programs.[© Dario Bajurin - Fotolia.com]](https://www.genengnews.com/wp-content/uploads/2018/08/Oct18_2011_3203632_BloodVessels_ServierMiragenCardioDeal1671558221-324x160.jpg "Servier and miRagen Sign $352M Deal for Cardiovascular miRNA Therapeutics")
